000			02275 a2200685 4500
005			20250515022851.0
264		0	_c20060517
008			200605s 0 0 eng d
022			_a0163-2116
024	7		_a10.1007/s10620-006-3177-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aIkeda, Kenji
245	0	0	_aA long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients. _h[electronic resource]
260			_bDigestive diseases and sciences _cMar 2006
300			_a603-9 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aCarcinoma, Hepatocellular _xepidemiology
650	0	4	_aCase-Control Studies
650	0	4	_aCohort Studies
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Resistance
650	0	4	_aFemale
650	0	4	_aGlycyrrhizic Acid _xadministration & dosage
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aInjections, Intravenous
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aLiver Function Tests
650	0	4	_aLiver Neoplasms _xepidemiology
650	0	4	_aLong-Term Care
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aProbability
650	0	4	_aPrognosis
650	0	4	_aRecombinant Proteins
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Assessment
650	0	4	_aSeverity of Illness Index
650	0	4	_aTreatment Outcome
700	1		_aArase, Yasuji
700	1		_aKobayashi, Masahiro
700	1		_aSaitoh, Satoshi
700	1		_aSomeya, Takashi
700	1		_aHosaka, Tetsuya
700	1		_aSezaki, Hitomi
700	1		_aAkuta, Norio
700	1		_aSuzuki, Yoshiyuki
700	1		_aSuzuki, Fumitaka
700	1		_aKumada, Hiromitsu
773	0		_tDigestive diseases and sciences _gvol. 51 _gno. 3 _gp. 603-9
856	4	0	_uhttps://doi.org/10.1007/s10620-006-3177-0 _zAvailable from publisher's website
999			_c16219838 _d16219838